Veleka Peeples-Dyer
CIK: 0001978705
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
REPL
Replimune Group, Inc.
Director
Discretionary Trading P&L
Holdings
About Peeples-Dyer Veleka
Peeples-Dyer Veleka (SEC CIK 0001978705) files insider reports with the SEC as Director of Replimune Group, Inc. (REPL).
Signal8 holds 2 ownership filings by Peeples-Dyer Veleka, all Form 4s, filed between Apr 3, 2025 and Apr 7, 2026. Those filings report 2 transactions, from Apr 1, 2025 to Apr 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Peeples-Dyer Veleka's filings is in WOBURN, MA.
Recent filings by Peeples-Dyer Veleka
Other insiders filing for Replimune Group, Inc. (REPL)
- Astley-Sparke Philip, Director
- Hill Emily Luisa, Chief Financial Officer
- Patel Sushil, Chief Executive Officer
- Xynos Konstantinos, Chief Medical Officer
- Schwendenman Andrew, Chief Accounting Officer
- BAKER BROS. ADVISORS LP, Director